Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQE Regulatory News (IQE)

Share Price Information for IQE (IQE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.70
Bid: 27.60
Ask: 28.05
Change: -0.40 (-1.42%)
Spread: 0.45 (1.63%)
Open: 27.45
High: 28.05
Low: 26.95
Prev. Close: 28.10
IQE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Partnership Agreement

27 Mar 2012 14:00

RNS Number : 1858A
IQE PLC
27 March 2012
 



IQE plc

 

IQE selected as partner in $2m Australian Solar Institute programme

 

Cardiff, UK, 27 March 2012: IQE plc (AIM: IQE, "IQE" or the "Group"), the leading global supplier of advanced semiconductor wafer products and services to the semiconductor industry, has been selected as a key CPV wafer supplier by Australian CPV company Silex Systems as part of a $2m programme to develop high efficiency multi-junction solar cells on low-cost large-area silicon substrates.

 

Silex Systems (ASX: SLX) received the $2 million grant from the Australian Solar Institute to support the company's development of solar cell technology which could reduce energy production costs by up to 20%.

 

The aim of the programme is to develop, fabricate, and test novel next-generation multiple-junction solar cells used in the evolving utility scale Concentrating Photovoltaic (CPV) solar power station industry.

 

The key differentiator is the development of a new virtual 'Germanium' substrate wafer-based substrate where a thin layer of Ge is deposited on a Silicon wafer. This will reduce the cost and potentially improve the efficiency of the multiple-junction cells in CPV applications. The new substrates and resulting CPV cell structures will be fully characterised and analysed in the lab and then tested in on-sun in field equipment.

 

The grant from the Australian Solar Institute (ASI) which was established by the Australian Government in 2009 is for the development of high efficiency multi-junction solar cells on low cost large area silicon substrates. The program, by Silex's wholly owned subsidiary Solar Systems, has the potential to reduce the cost of energy production from Concentrating Photovoltaic technologies by up to 20%.

 

Solar Systems will supplement the $2 million grant by providing about $3 million in project funding, with $2 million of in-kind support and $1 million in cash contributions over the three year project duration.

 

Project partner and Silex subsidiary Translucent will provide large area silicon substrate technology for the project, allowing for commercialisation of the technology to be fast tracked.

 

Dr. Andrew Johnson, IQE's CPV Technology Director said:

 

"Silex Systems' selection of IQE as a partner for this programme clearly demonstrates that we are recognised as a key global player in CPV wafer products for advanced, high efficiency solar energy generation. This programme builds on our advanced capabilities in germanium on silicon for CPV applications that we launched in 2010 and compliments the range of CPV technologies in which we are active."

 

Other key CPV partners in the programme include Boeing-owned Spectrolab and Emcore Corporation for multi-junction cell production facilities.

 

These partnerships will allow for volume production of the solar cells, which will be incorporated into Solar Systems' dense array system to characterise the performance of the new CPV modules at the Bridgewater Test Facility in central Victoria.

 

 

 

FURTHER INFORMATION

 

IQE: www.iqep.com

Silex Systems: http://www.silex.com.au/

Australian Solar Institute: www.australiansolarinstitute.com.au/

 

 

CONTACTS:

IQE plc (+44 29 2083 9400)

Press: Chris Meadows

Technical: Dr Andrew Johnson

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAPGUQCWUPPGPM
Date   Source Headline
8th Mar 20133:00 pmRNSMerger Update
8th Jan 20138:39 amRNSStatement regarding press articles
31st Jul 20123:54 pmRNSDirectorate Change
10th Apr 20125:11 pmRNSDirector Dealings
27th Mar 20122:00 pmRNSPartnership Agreement
8th Feb 20124:10 pmRNSCompletion of Placing
17th Feb 20103:56 pmRNSNominated Adviser Change of Name
7th Aug 20094:42 pmRNSHolding(s) in Company
7th Aug 20094:30 pmRNSBondholders meeting
7th Aug 20093:51 pmRNSDirector Dealing in Shares
12th Jun 20081:42 pmRNSAdditional Listing
15th Apr 20087:01 amRNSAdditional Listing
7th Apr 200812:14 pmRNSDirector/PDMR Shareholding
28th Mar 200811:52 amRNSDirector/PDMR Shareholding
19th Mar 20087:00 amRNSDirector/PDMR Shareholding
17th Mar 20081:00 pmRNSContract Win
17th Mar 20087:01 amRNSFinal Results
28th Feb 20083:27 pmRNSHolding(s) in Company
19th Feb 20088:30 amRNSNotice of Results
25th Jan 20087:00 amRNSBank Facilities
17th Jan 20087:00 amRNSTrading Update
16th Jan 200811:15 amRNSBroker Appointment
15th Jan 200812:12 pmRNSDirector/PDMR Shareholding
9th Jan 20084:26 pmRNSAdditional Listing
7th Jan 20087:00 amRNSDirector/PDMR Shareholding
4th Jan 200812:46 pmRNSHolding(s) in Company
19th Dec 20077:30 amRNSAdditional Listing
18th Dec 20073:52 pmRNSSubstrate supply contract
13th Dec 20077:01 amRNSSuccessful Qualifications
9th Nov 200710:53 amRNSDirector/PDMR Shareholding
3rd Oct 200710:41 amRNSDirector/PDMR Shareholding
1st Oct 20072:44 pmRNSAdditional Listing
28th Sep 200710:14 amRNSContract Win
28th Sep 20078:12 amRNSInvestor Presentation
4th Sep 200712:03 pmRNSDirector/PDMR Shareholding
28th Aug 20072:17 pmRNSHolding(s) in Company
24th Aug 20073:36 pmRNSHolding(s) in Company
22nd Aug 20077:01 amRNSContract Win
22nd Aug 20077:01 amRNSInterim Results
15th Aug 20077:01 amRNSIFRS Transitional Stmnt - Amd
14th Aug 20077:01 amRNSIFRS Transitional Statement
13th Aug 20071:19 pmRNSRule 26 Compliance
2nd Aug 20078:39 amRNSResearch Consortium
1st Aug 20073:52 pmRNSNotice of Results
25th Jul 20071:35 pmRNSResult of AGM
11th Jul 20078:00 amRNSHolding(s) in Company
9th Jul 20077:00 amRNSTrading Statement
18th Jun 20073:35 pmRNSHolding(s) in Company
4th Jun 20074:15 pmRNSHolding(s) in Company
29th May 20074:48 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.